Diebold Nixdorf
DBD
65.04
-0.44
-0.67%
Diebold Nixdorf
US · DBD
#2716 by market cap
Listed 1970
65.04
-0.44
-0.67%
Live - 5344 symbols - heartbeat 104s ago
· 2026-10-07 19:54
After-hours
65.04
0.00%
- Market cap
- 2.21B
- P/E (TTM)i
- 21.54
- P/Bi
- 2.28
- EPSi
- 2.54
- Div yieldi
- 0.00%
- 52W posi
- 28%
Reader sentiment
Are you bullish or bearish on DBD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.84, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.46% YoY
Margins
- Gross margin
- 25.26%
- Operating margin
- 6.36%
- Net margin
- 2.49%
Key ratios & quality
- Altman Z-Scorei
- 1.84
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.58B | 4.41B | 3.90B | 3.91B | 3.46B | -- | 3.75B | 3.81B |
| Gross profit | 898.80M | 1.07B | 1.04B | 1.04B | 757.30M | -- | 920.00M | 961.20M |
| Selling & admin expenses | 893.50M | 908.80M | 858.60M | 775.60M | 741.60M | -- | 643.60M | 632.50M |
| Research & development | 157.40M | 147.10M | 133.40M | 126.30M | 120.70M | -- | 93.60M | 86.70M |
| Operating profit | -152.10M | 11.20M | 43.00M | 141.50M | -105.00M | -- | 182.80M | 242.00M |
| Pretax profit | -478.30M | -228.90M | -269.50M | -50.70M | -438.60M | -- | 47.30M | 125.10M |
| Tax | 37.20M | 116.70M | -1.00M | 27.70M | 149.20M | -- | 64.30M | 24.10M |
| Net profit | -528.70M | -344.60M | -267.80M | -78.10M | -585.60M | -- | -14.50M | 97.50M |
| Basic EPS | -7 | -4 | -3 | -1 | -7 | -- | 0 | 3 |
| Diluted EPS | -6.99 | -4.45 | -3.47 | -1.01 | -7.36 | -- | -0.44 | 2.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 841.10M | 915.20M | 945.20M | 1.10B | 891.80M | 930.80M |
| Gross profit | 202.40M | 234.00M | 245.10M | 279.80M | 213.10M | 239.60M |
| Selling & admin expenses | 145.00M | 147.90M | 150.90M | 175.60M | 145.30M | 147.80M |
| Research & development | 22.70M | 22.40M | 20.30M | 21.40M | 22.10M | 20.50M |
| Operating profit | 36.40M | 62.50M | 73.80M | 82.40M | 44.60M | 71.90M |
| Pretax profit | -7.40M | 17.20M | 52.40M | 62.80M | 12.40M | 36.30M |
| Tax | -2.20M | 4.80M | 9.60M | 11.90M | 5.70M | 19.20M |
| Net profit | -7.50M | 12.70M | 41.70M | 50.50M | 5.50M | 16.20M |
| Basic EPS | 0 | 0 | 1 | 1 | 0 | 0 |
| Diluted EPS | -0.22 | 0.33 | 1.11 | 1.37 | 0.14 | 0.44 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.20B | 1.89B | 1.86B | 1.89B | 1.77B | 2.15B | 1.67B | 1.79B |
| Cash & ST investments | 491.90M | 290.90M | 361.70M | 423.20M | 332.00M | 563.60M | 313.10M | 398.00M |
| Inventory | 610.10M | 466.50M | 498.20M | 544.20M | 588.10M | 589.80M | 528.10M | 521.00M |
| Total assets | 4.28B | 3.79B | 3.66B | 3.51B | 3.07B | 4.16B | 3.54B | 3.85B |
| Total current liabilities | 1.57B | 1.60B | 1.65B | 1.75B | 1.60B | 1.42B | 1.27B | 1.37B |
| Short-term debt | 49.50M | 95.30M | 66.40M | 101.60M | 63.00M | 39.90M | -- | -- |
| Long-term debt | 2.19B | 2.11B | 2.34B | 2.25B | 2.59B | 1.25B | 927.30M | 938.50M |
| Total liabilities | 4,273,000,000.00 | 4,276,000,000.00 | 4,469,900,000.00 | 4,344,200,000.00 | 4,436,100,000.00 | 3,082,800,000.00 | 2,605,300,000.00 | 2,749,600,000.00 |
| Total equity | 7.50M | -485.40M | -812.50M | -837.00M | -1.37B | 1.08B | 938.20M | 1.10B |
| Retained earnings | -131.00M | -472.30M | -742.30M | -822.40M | -1.41B | 17.10M | -1.10M | 91.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.73B | 1.74B | 1.72B | 1.79B | 1.80B | 1.71B |
| Cash & ST investments | 314.60M | 294.40M | 263.50M | 398.00M | 373.60M | 282.40M |
| Inventory | 553.00M | 574.00M | 599.70M | 521.00M | 553.10M | 595.90M |
| Total assets | 3.63B | 3.74B | 3.72B | 3.85B | 3.83B | 3.74B |
| Total current liabilities | 1.28B | 1.27B | 1.26B | 1.37B | 1.40B | 1.35B |
| Short-term debt | 47.33M | 48.70M | -- | -- | -- | -- |
| Long-term debt | 928.70M | 931.10M | 934.00M | 938.50M | 939.40M | 942.90M |
| Total liabilities | 2,634,600,000.00 | 2,634,900,000.00 | 2,611,400,000.00 | 2,749,600,000.00 | 2,803,700,000.00 | 2,760,100,000.00 |
| Total equity | 991.00M | 1.11B | 1.11B | 1.10B | 1.03B | 976.50M |
| Retained earnings | -9.40M | 2.80M | 43.90M | 91.90M | 96.90M | 112.40M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -104.10M | 135.80M | 18.00M | 123.30M | -387.90M | -- | 149.20M | 300.70M |
| Depreciation & amortization | 234.20M | 204.30M | 180.40M | 149.10M | 126.00M | -- | 132.30M | 127.50M |
| Free cash flow | -192.40M | 69.80M | -26.70M | 72.00M | -441.00M | -- | 108.80M | 239.00M |
| Dividends paid | -7.70M | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | 0 | -130.70M |
| Ending cash balance | 458.40M | 280.90M | 324.50M | 388.90M | 319.10M | -- | 311.30M | 387.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 15.70M | 30.10M | 37.40M | 217.50M | 31.70M | -13.60M |
| Depreciation & amortization | 33.90M | 31.20M | 31.70M | 30.70M | 31.40M | 30.80M |
| Free cash flow | 6.10M | 12.70M | 24.50M | 195.70M | 20.70M | -28.90M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -9.60M | -30.10M | -39.90M | -51.10M | -60.40M | -60.60M |
| Ending cash balance | 320.20M | 295.20M | 262.60M | 387.30M | 373.60M | 282.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -401.06 | -- | -- | -- | -- | -- | -1.66 | 9.32 |
| ROA %i | -11.89 | -8.42 | -7.23 | -2.20 | -17.69 | -- | -0.43 | 2.56 |
| ROIC %i | -21.11 | -- | -- | -- | -- | -- | 4.39 | 7.88 |
| 5-year avg ROE %i | -75.65 | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -7.88 | -0.59 | 0.59 | 3.70 | -6.92 | -- | 5.40 | 5.54 |
| FCF / sales %i | -- | 2.11 | -- | 1.84 | -- | -- | 2.90 | 6.28 |
| Current ratioi | 1.40 | 1.18 | 1.13 | 1.08 | 1.10 | 1.52 | 1.32 | 1.30 |
| Quick ratioi | 0.78 | 0.57 | 0.61 | 0.58 | 0.59 | 0.90 | 0.71 | 0.73 |
| Debt / assetsi | 52.32 | 60.95 | 68.22 | 69.86 | 88.92 | 32.61 | 26.17 | 24.35 |
| LT debt / equityi | -- | -- | -- | -- | -- | 123.85 | 99.73 | 85.33 |
| Interest coveragei | -2.33 | -0.13 | 0.08 | 0.74 | -1.20 | -- | 1.30 | 2.46 |
| Revenue CAGR (3Y) %i | 23.69 | 9.96 | -5.40 | -5.16 | -7.75 | -- | -1.33 | 3.22 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 14.75 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.02 | -1.23 | 4.66 | 9.32 | 10.75 | 10.76 |
| ROA %i | -0.27 | -0.34 | 1.33 | 2.56 | 2.89 | 2.97 |
| ROIC %i | 4.20 | 3.38 | 5.64 | 7.88 | 8.50 | 8.37 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.07 | 3.88 | 4.57 | 5.54 | 6.03 | 6.55 |
| FCF / sales %i | 4.09 | 4.90 | 6.22 | 6.28 | 6.58 | 5.48 |
| Current ratioi | 1.35 | 1.36 | 1.36 | 1.30 | 1.28 | 1.27 |
| Quick ratioi | 0.71 | 0.70 | 0.67 | 0.73 | 0.69 | 0.69 |
| Debt / assetsi | 29.10 | 28.42 | 25.08 | 24.35 | 24.53 | 25.23 |
| LT debt / equityi | 102.42 | 92.44 | 84.36 | 85.33 | 91.84 | 97.29 |
| Interest coveragei | 1.41 | 1.22 | 1.69 | 2.46 | 2.66 | 2.83 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Banking is the largest reported line at 68.45% of revenue, across 2 reported segments.
- Retail follows at 31.55%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Banking68.45%
Retail31.55%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.